Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • brentonmar
    Junior Member
    • Jan 2012
    • 1

    Quantifying allele fraction of small to medium deletions in amplication sequencing

    Hi all,

    I would like to use MiSeq amplicon sequencing to detect the clonal outgrowth of cells harboring small to medium sized deletions (1bp to 160bp) in specific genes generated using CRISPR technology (which makes random sized deletions at specific loci matching a DNA template).

    I've used BWA/Varscan in the past to quantify the allele fraction of small (1-3bp) deletions. I've also used pindel to qualitatively identify larger deletions, but I'm unsure if one can quantatively estimate the allele fraction of deletion using pindel or other tools. Has anyone tried this or have any advice?

    Thanks!
    -Brenton
  • chrisamiller
    Junior Member
    • Jun 2008
    • 7

    #2
    It's a challenging issue that usually requires several steps:

    1) local assembly to identify the exact sequence of the large indel
    2) creation of a contig containing that sequence
    3) competitive realignment to discover reads that span the breakpoint, but couldn't be mapped previously

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...